Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. (Q36047450)

11 August 2017

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. (English)

1 reference

11 August 2017

0 references

1 reference

Vuk Stambolic

20

0 references

Bingshu E. Chen

object named as

Bingshu E Chen

19

0 references

Pamela J Goodwin

object named as

Pamela J Goodwin

1

0 references

Dawn L. Hershman

6

object named as

Dawn L Hershman

1 reference

11 August 2017

5

Jennifer A Ligibel

1 reference

11 August 2017

Wendy R Parulekar

2

1 reference

11 August 2017

Karen A Gelmon

3

1 reference

11 August 2017

Lois E Shepherd

4

1 reference

11 August 2017

Priya Rastogi

7

1 reference

11 August 2017

Ingrid A Mayer

8

1 reference

11 August 2017

Timothy J Hobday

9

1 reference

11 August 2017

Julie Lemieux

10

1 reference

11 August 2017

Alastair M Thompson

11

1 reference

11 August 2017

Kathleen I Pritchard

12

1 reference

11 August 2017

Timothy J Whelan

13

1 reference

11 August 2017

Som D Mukherjee

14

1 reference

11 August 2017

Haji I Chalchal

15

1 reference

11 August 2017

Conrad D Oja

16

1 reference

11 August 2017

Katia S Tonkin

17

1 reference

11 August 2017

Vanessa Bernstein

18

1 reference

11 August 2017

language of work or name

English

0 references

publication date

4 March 2015

1 reference

Journal of the National Cancer Institute

11 August 2017

1 reference

11 August 2017

107

1 reference

11 August 2017

3

1 reference

Metformin in cancer: translational challenges

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Molecular mechanisms of cancer development in obesity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Role of AMP-activated protein kinase in mechanism of metformin action

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Metabolic profile, physical activity, and mortality in breast cancer patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Insulin-lowering effects of metformin in women with early breast cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Metabolic syndrome as a prognostic factor for breast cancer recurrences

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Is leptin a mediator of adverse prognostic effects of obesity in breast cancer?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565534

23 September 2018

Identifiers

DOI

10.1093/JNCI/DJV006

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

25740979

1 reference